Population Genomics Market Report 2026

The population genomics market size has grown rapidly in recent years. It will grow from $8.44 billion in 2025 to $9.65 billion in 2026 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to expansion of national genomics initiatives, increasing research funding for population studies, growth in biobank infrastructure, advances in sequencing technologies, rising demand for genetic diversity studies.

The population genomics market size is expected to see rapid growth in the next few years. It will grow to $16.34 billion in 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing application of population genomics in personalized medicine, rising investments in global genomics collaborations, expansion of ai-driven genomic interpretation, growing use of genomics in public health planning, increasing adoption of scalable data management systems. Major trends in the forecast period include increasing deployment of large-scale population sequencing projects, rising use of advanced variant annotation tools, growing integration of population genomics with clinical research, expansion of cloud-based genomics platforms, enhanced focus on data standardization.

The rising demand for personalized medicine is expected to propel the growth of the population genomics market going forward. Declining genomic technology costs are increasing access to targeted therapies. Population genomics identifies population-specific genetic variations to support treatment customization. For instance, FDA approvals for personalized treatments increased significantly in 2023. Therefore, rising demand for personalized medicine is driving the growth of the population genomics market.

Leading companies operating in the population genomics market are focusing on developing advanced solutions, such as ultra-high-throughput library preparation kits, to improve sample consistency, streamline large-scale sequencing workflows, and reduce per-sample processing costs. Ultra-high-throughput library preparation kits are specialized next-generation sequencing (NGS) workflow tools that enable rapid preparation, normalization, and pooling of hundreds to thousands of DNA or RNA samples in a single, scalable process suitable for population-scale genomic studies. For instance, in October 2024, Twist Bioscience Corporation, a US-based biotechnology company, launched FlexPrep, an ultra-high-throughput library preparation kit that incorporates Normalization by Ligation (NBL) technology to eliminate the need for upfront sample quantification, supports early pooling and multiplexing to simplify handling of variable input samples, and uses a proprietary Twist-developed enzyme to enable high-volume, cost-efficient processing for population genomics NGS applications.

In August 2024, Hitachi High-Tech Corporation, a Japan-based manufacturer of electronic and electrical equipment and systems, acquired Nabsys for an undisclosed amount. Through this acquisition, Hitachi High-Tech aims to accelerate adoption of OhmX technology to advance diagnostics, prognostics, and therapeutic research while strengthening its molecular diagnostics business. Nabsys is a US-based company specializing in population genomics.

Major companies operating in the population genomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Illumina Inc., Charles River Laboratories, Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Takara Bio Inc, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Color Genomics Inc., Helix OpCo LLC, Personalis Inc., Centogene N.V., Genomics England Limited, Veritas Genetics Inc., Genuity Science, Gene by Gene Ltd., Nebula Genomics Inc., Ancestry.com LLC.

North America was the largest region in the population genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the population genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the population genomics market by increasing costs of imported sequencing instruments, laboratory automation systems, data storage hardware, and advanced bioinformatics software. Academic institutions and research organizations in North America and Europe are most affected due to reliance on imported genomics infrastructure, while Asia-Pacific faces cost pressures on large-scale sequencing programs. These tariffs are increasing project budgets and extending research timelines. However, they are also encouraging domestic manufacturing of sequencing tools, regional software development, and localized genomics research infrastructure investment.

The population genomics market research report is one of a series of new reports that provides population genomics market statistics, including population genomics industry global market size, regional shares, competitors with a population genomics market share, detailed population genomics market segments, market trends and opportunities, and any further data you may need to thrive in the population genomics industry. This population genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Population genomics is a scientific field that studies genetic similarities and differences across entire populations by analyzing their complete genomes. It explores how evolutionary forces such as natural selection, migration, genetic drift, and adaptation shape the genetic composition of populations over time.

The primary product services of population genomics include consumables, instruments, services, and software. Consumables include single-use laboratory materials such as reagents, test kits, assay plates, pipette tips, and cartridges required for experimental workflows. These services support sample types including human, animal, plant, and microbial and are applied in pharmacogenomics, disease research, ancestry and evolutionary studies, personalized medicine, and others, serving end-users such as academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

The population genomics market consists of revenues earned by entities by providing services such as whole genome sequencing, population structure analysis, evolutionary analysis, and variant annotation. The market value includes the value of related goods sold by the service provider or included within the service offering. The population genomics market also includes sales of next-generation sequencers, microarray scanners, imaging systems, and SNP analysis instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.